Business Context and Reporting Period
Company: American Vanguard Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: December 23, 2003
Event: Acquisition of specific assets by AMVAC Chemical Corporation, a wholly owned subsidiary.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Asset Acquisition: On December 23, 2003, AMVAC Chemical Corporation completed the acquisition of assets related to the active ingredient dichlorvos ("DDVP").
- Product Details: The acquired assets are used in the animal health business and are marketed primarily under the trade name Nuvan.
- Counterparty: The assets were acquired from Novartis Animal Health, Inc., a business unit of Novartis AG.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors related to this transaction. The report refers to a press release (Exhibit 99.1) for further details.
Investor Verification Checklist
- Verify the purchase price and payment terms of the DDVP asset acquisition (not disclosed in this summary).
- Review the full text of the press release (Exhibit 99.1) for strategic rationale and expected impact on the animal health segment.
- Confirm any regulatory approvals required for the transfer of assets from Novartis Animal Health, Inc.